The risks associated with percutaneous native kidney biopsies: a prospective study.
Simeone AndrulliMichele RossiniGiuseppe GigliottiGaetano La MannaSandro FeriozziFilippo AucellaAntonio GranataElisabetta MoggiaDomenico SantoroLucio ManentiBarbara InfanteAngelo FerrantelliRosario CianciMario GiordanoDomenico GianneseGiuseppe SeminaraMarina Di LucaMario BonominiLeonardo SpatolaFrancesca BrunoOlga BaraldiDavid MicarelliMatteo PiemonteseGiulio DistefanoFrancesca MattozziPaola De GiovanniDavide PennaMaurizio GarozzoLuigi VernaglioneCataldo AbaterussoFulvia ZanchelliRachele BrugnanoEnrica GintoliLaura SottiniMarco QuagliaGioacchino Li CavoliMarco De FabritiisMaria Maddalena ConteMassimo ManesBattaglia YuriFrancesco FontanaLoreto GesualdoPublished in: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association (2022)
This is the first multicentre prospective study showing that percutaneous native kidney biopsies are associated with a 5% risk of a major post-biopsy complication. Predictors of increased risk include higher plasma creatinine levels, liver disease, and a higher number of needle passes.